SOLIGENIX, INC. — Director's Dealing 2009

Aug 11, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DOR.OB)
CIK: 0000812796
Period of Report: 2009-07-30

Reporting Person: Biotex Pharma Investments, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-07-30	Common Stock	S	500000	$.2049	Disposed	19500000	Direct
2009-08-11	Common Stock	S	500000	$.2000	Disposed	19000000	Direct